Banka BioLoo Limited (NSE:BANKA)
India · Delayed Price · Currency is INR 64.42
+1.19 (1.88%)
Jan 23, 2026, 3:26 PM IST
Banka BioLoo Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 530.3 | 541.74 | 499.96 | 423.5 | 387.51 | 304.58 | Upgrade |
Other Revenue | - | - | -0 | - | - | - | Upgrade |
| 530.3 | 541.74 | 499.96 | 423.5 | 387.51 | 304.58 | Upgrade | |
Revenue Growth (YoY) | -4.57% | 8.36% | 18.05% | 9.29% | 27.23% | -36.37% | Upgrade |
Cost of Revenue | 433.46 | 453.24 | 403.04 | 293.34 | 246.27 | 169.32 | Upgrade |
Gross Profit | 96.84 | 88.5 | 96.92 | 130.15 | 141.24 | 135.25 | Upgrade |
Selling, General & Admin | 67.18 | 57.97 | 36.21 | 4.14 | 4.05 | 9.07 | Upgrade |
Other Operating Expenses | 27.68 | 59.21 | 23.29 | 65.6 | 81.47 | 92.1 | Upgrade |
Operating Expenses | 121.17 | 142.48 | 81.39 | 84.57 | 94.93 | 107.15 | Upgrade |
Operating Income | -24.33 | -53.98 | 15.54 | 45.59 | 46.31 | 28.11 | Upgrade |
Interest Expense | -34.83 | -33.82 | -22.76 | -15 | -16.41 | -14.65 | Upgrade |
Interest & Investment Income | 2.51 | 2.51 | 3.78 | 5.56 | 3.91 | - | Upgrade |
Earnings From Equity Investments | 0.48 | 0.28 | -0.21 | 0.06 | 0.27 | -0.02 | Upgrade |
Currency Exchange Gain (Loss) | 0.62 | 0.62 | - | - | - | -0.02 | Upgrade |
Other Non Operating Income (Expenses) | 5.35 | -3.74 | -1.99 | 0.03 | -0.97 | 5.27 | Upgrade |
EBT Excluding Unusual Items | -50.21 | -88.13 | -5.63 | 36.24 | 33.11 | 18.68 | Upgrade |
Impairment of Goodwill | - | -3.15 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 0.04 | 0.04 | - | - | -0.03 | - | Upgrade |
Pretax Income | -50.17 | -91.24 | -5.63 | 36.24 | 33.08 | 18.68 | Upgrade |
Income Tax Expense | -8.59 | -2.15 | 1.08 | 10.85 | 2.01 | -3.36 | Upgrade |
Earnings From Continuing Operations | -41.57 | -89.09 | -6.71 | 25.39 | 31.08 | 22.05 | Upgrade |
Minority Interest in Earnings | -0.02 | -0.06 | 0.19 | - | - | -0 | Upgrade |
Net Income | -41.6 | -89.15 | -6.53 | 25.39 | 31.08 | 22.05 | Upgrade |
Net Income to Common | -41.6 | -89.15 | -6.53 | 25.39 | 31.08 | 22.05 | Upgrade |
Net Income Growth | - | - | - | -18.30% | 40.95% | -64.59% | Upgrade |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 10 | 10 | Upgrade |
Shares Change (YoY) | 0.68% | -1.00% | 1.67% | 4.85% | 0.18% | - | Upgrade |
EPS (Basic) | -3.82 | -8.22 | -0.60 | 2.35 | 3.02 | 2.14 | Upgrade |
EPS (Diluted) | -3.83 | -8.22 | -0.60 | 2.34 | 3.02 | 2.14 | Upgrade |
EPS Growth | - | - | - | -22.44% | 40.98% | -64.67% | Upgrade |
Free Cash Flow | -0.79 | -36.13 | -72.07 | 9.4 | -36 | 53.55 | Upgrade |
Free Cash Flow Per Share | -0.07 | -3.32 | -6.56 | 0.87 | -3.50 | 5.21 | Upgrade |
Gross Margin | 18.26% | 16.34% | 19.39% | 30.73% | 36.45% | 44.41% | Upgrade |
Operating Margin | -4.59% | -9.96% | 3.11% | 10.76% | 11.95% | 9.23% | Upgrade |
Profit Margin | -7.84% | -16.46% | -1.31% | 6.00% | 8.02% | 7.24% | Upgrade |
Free Cash Flow Margin | -0.15% | -6.67% | -14.41% | 2.22% | -9.29% | 17.58% | Upgrade |
EBITDA | -3.72 | -34.37 | 31.72 | 54.74 | 51.93 | 33.38 | Upgrade |
EBITDA Margin | -0.70% | -6.35% | 6.35% | 12.93% | 13.40% | 10.96% | Upgrade |
D&A For EBITDA | 20.62 | 19.61 | 16.19 | 9.15 | 5.62 | 5.27 | Upgrade |
EBIT | -24.33 | -53.98 | 15.54 | 45.59 | 46.31 | 28.11 | Upgrade |
EBIT Margin | -4.59% | -9.96% | 3.11% | 10.76% | 11.95% | 9.23% | Upgrade |
Effective Tax Rate | - | - | - | 29.94% | 6.07% | - | Upgrade |
Revenue as Reported | 542.66 | 545.01 | 504.91 | 430.51 | 392.05 | 310.34 | Upgrade |
Advertising Expenses | - | 0.57 | 0.51 | 1.94 | 0.3 | 0.98 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.